Furthermore, the BRD4 inhibitor (+)-JQ1 (JQ1) has been shown to suppress the proliferation of cancer cells4,5, indicating that JQ1 may be a new therapeutic agent for cancer treatment. This evidence concerns the gene BRD4 and cancer.